FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2108790123> ?p ?o ?g. }

• W2108790123 endingPage "32" @default.
• W2108790123 startingPage "26" @default.
• W2108790123 abstract "We sought to evaluate the impact of intravenous antagonists of the platelet IIb/IIIa receptor on the survival of patients undergoing percutaneous coronary interventions (PCIs).Several trials have shown that intravenous antagonists of the platelet glycoprotein (GP) IIb/IIIa receptor reduce the incidence of myocardial infarction (MI) and composite cardiac outcomes (death, MI, or revascularization) in patients undergoing PCI. However, individual studies have not had adequate power to examine differences in mortality.We performed a meta-analysis of 19 randomized, placebo-controlled trials (20 comparisons, n = 20,137). Death was the primary outcome. Secondary outcomes included MI, composite cardiac outcomes, and major bleeding.Mortality was significantly reduced at 30 days (risk ratio [RR] 0.69 [95% confidence interval [CI] 0.53 to 0.90]), at six months (RR 0.79 [95% CI 0.64 to 0.97]), and including longer follow-up (RR 0.79 [95% CI 0.66 to 0.94]), with no significant between-study heterogeneity. The relative risk reduction was largely similar in trials of patients with or without acute myocardial infarction (AMI), in trials continuing or discontinuing heparin after the procedure, and in trials using stents or another PCI as the intended primary procedure. Myocardial infarction and composite outcomes were significantly reduced (p < 0.001 for all) at 30 days and six months. Major bleeding was significantly increased only in trials where heparin infusion was continued after the procedure (RR 1.70 [95% CI 1.36 to 2.14]), although there was no excess bleeding when heparin was discontinued (RR 1.02 [95% CI 0.85 to 1.24]).In patients undergoing PCI, GP IIb/IIIa receptor antagonists confer a significant and sustained decrease (20% to 30%) in the risk of death." @default.
• W2108790123 created "2016-06-24" @default.
• W2108790123 creator A5011767703 @default.
• W2108790123 creator A5062732706 @default.
• W2108790123 creator A5070446713 @default.
• W2108790123 date "2003-01-01" @default.
• W2108790123 modified "2023-10-17" @default.
• W2108790123 title "Intravenous glycoprotein IIb/IIIa receptor antagonists reduce mortality after percutaneous coronary interventions" @default.
• W2108790123 cites W1964435302 @default.
• W2108790123 cites W1984258208 @default.
• W2108790123 cites W1984441154 @default.
• W2108790123 cites W1984761420 @default.
• W2108790123 cites W1993578099 @default.
• W2108790123 cites W1994478916 @default.
• W2108790123 cites W1994543623 @default.
• W2108790123 cites W2007516629 @default.
• W2108790123 cites W2010111546 @default.
• W2108790123 cites W2016562783 @default.
• W2108790123 cites W2035015235 @default.
• W2108790123 cites W2052694025 @default.
• W2108790123 cites W2059215195 @default.
• W2108790123 cites W2081799397 @default.
• W2108790123 cites W2099058771 @default.
• W2108790123 cites W2121729095 @default.
• W2108790123 cites W2124788115 @default.
• W2108790123 cites W2141117188 @default.
• W2108790123 cites W2152307503 @default.
• W2108790123 cites W2152867297 @default.
• W2108790123 cites W2168079615 @default.
• W2108790123 cites W2168494093 @default.
• W2108790123 cites W2230838014 @default.
• W2108790123 cites W2281862598 @default.
• W2108790123 cites W2313726388 @default.
• W2108790123 cites W2324899882 @default.
• W2108790123 cites W2333133657 @default.
• W2108790123 cites W2568050971 @default.
• W2108790123 cites W2619044267 @default.
• W2108790123 cites W3022148767 @default.
• W2108790123 cites W4254730674 @default.
• W2108790123 cites W89469075 @default.
• W2108790123 doi "https://doi.org/10.1016/s0735-1097(02)02666-9" @default.
• W2108790123 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/12570940" @default.
• W2108790123 hasPublicationYear "2003" @default.
• W2108790123 type Work @default.
• W2108790123 sameAs 2108790123 @default.
• W2108790123 citedByCount "164" @default.
• W2108790123 countsByYear W21087901232012 @default.
• W2108790123 countsByYear W21087901232013 @default.
• W2108790123 countsByYear W21087901232014 @default.
• W2108790123 countsByYear W21087901232015 @default.
• W2108790123 countsByYear W21087901232016 @default.
• W2108790123 countsByYear W21087901232018 @default.
• W2108790123 countsByYear W21087901232019 @default.
• W2108790123 countsByYear W21087901232020 @default.
• W2108790123 countsByYear W21087901232021 @default.
• W2108790123 countsByYear W21087901232023 @default.
• W2108790123 crossrefType "journal-article" @default.
• W2108790123 hasAuthorship W2108790123A5011767703 @default.
• W2108790123 hasAuthorship W2108790123A5062732706 @default.
• W2108790123 hasAuthorship W2108790123A5070446713 @default.
• W2108790123 hasBestOaLocation W21087901231 @default.
• W2108790123 hasConcept C126322002 @default.
• W2108790123 hasConcept C141071460 @default.
• W2108790123 hasConcept C142724271 @default.
• W2108790123 hasConcept C164705383 @default.
• W2108790123 hasConcept C168563851 @default.
• W2108790123 hasConcept C204787440 @default.
• W2108790123 hasConcept C27081682 @default.
• W2108790123 hasConcept C2777557582 @default.
• W2108790123 hasConcept C2779464278 @default.
• W2108790123 hasConcept C2780400711 @default.
• W2108790123 hasConcept C44249647 @default.
• W2108790123 hasConcept C45393284 @default.
• W2108790123 hasConcept C500558357 @default.
• W2108790123 hasConcept C71924100 @default.
• W2108790123 hasConcept C82789193 @default.
• W2108790123 hasConceptScore W2108790123C126322002 @default.
• W2108790123 hasConceptScore W2108790123C141071460 @default.
• W2108790123 hasConceptScore W2108790123C142724271 @default.
• W2108790123 hasConceptScore W2108790123C164705383 @default.
• W2108790123 hasConceptScore W2108790123C168563851 @default.
• W2108790123 hasConceptScore W2108790123C204787440 @default.
• W2108790123 hasConceptScore W2108790123C27081682 @default.
• W2108790123 hasConceptScore W2108790123C2777557582 @default.
• W2108790123 hasConceptScore W2108790123C2779464278 @default.
• W2108790123 hasConceptScore W2108790123C2780400711 @default.
• W2108790123 hasConceptScore W2108790123C44249647 @default.
• W2108790123 hasConceptScore W2108790123C45393284 @default.
• W2108790123 hasConceptScore W2108790123C500558357 @default.
• W2108790123 hasConceptScore W2108790123C71924100 @default.
• W2108790123 hasConceptScore W2108790123C82789193 @default.
• W2108790123 hasIssue "1" @default.
• W2108790123 hasLocation W21087901231 @default.
• W2108790123 hasLocation W21087901232 @default.
• W2108790123 hasOpenAccess W2108790123 @default.
• W2108790123 hasPrimaryLocation W21087901231 @default.
• W2108790123 hasRelatedWork W2030705936 @default.
• W2108790123 hasRelatedWork W2163807027 @default.

• next